H
Herbert Pilgrimm
Publications - 10
Citations - 679
Herbert Pilgrimm is an academic researcher. The author has contributed to research in topics: Magnetic resonance imaging & Contrast medium. The author has an hindex of 9, co-authored 10 publications receiving 657 citations.
Papers
More filters
Journal ArticleDOI
Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging.
Matthias Taupitz,Susanne Wagner,Jörg Schnorr,Irina Kravec,Herbert Pilgrimm,F. Henrike Bergmann-Fritsch,Bernd Hamm +6 more
TL;DR: The favorable data on the safety, tolerability, and efficacy of VSOP-C184 justify further clinical phase II and III trials as a contrast medium for MRI.
Journal ArticleDOI
Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.
TL;DR: The experiments indicate, that VSOP-C184 may be a well tolerated and safe contrast medium for MR imaging that can be effectively used for MR angiography including visualization of the coronary arteries.
Journal ArticleDOI
In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking.
Gerrit Fleige,Florian Seeberger,Daniela Laux,Mayk Kresse,Matthias Taupitz,Herbert Pilgrimm,Claus Zimmer +6 more
TL;DR: Citrate-coated USPIO particles VSOP-C125 appear to have more favorable properties for magnetic labeling of macrophages than the carboxydextran-coating USPio preparation DDM 43/34/103.
Journal ArticleDOI
New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Matthias Taupitz,Jörg Schnorr,Claudia Abramjuk,Susanne Wagner,Herbert Pilgrimm,Hanna Hünigen,Bernd Hamm +6 more
TL;DR: The monomer‐coated, iron oxide‐based contrast medium VSOP‐C63 exhibits favorable properties as a blood pool agent for both equilibrium and first‐pass MRA.
Journal ArticleDOI
Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
Jörg Schnorr,Susanne Wagner,Claudia Abramjuk,Ines Wojner,Tania Schink,Thomas J. Kroencke,Eyk Schellenberger,Bernd Hamm,Herbert Pilgrimm,Matthias Taupitz +9 more
TL;DR: VSOP-C184 is suitable for first-pass MRA at doses of 0.025 and 0.035 mmol Fe/kg and thus, in addition to its blood pool characteristics, allows for selective visualization of the arteries without interfering venous signal.